Test a special MRI to screen high-risk prostate cancer
Part of Cancer, Kidney & urinary clinical trials.
This study checks whether a detailed MRI method can help find prostate cancer earlier in people considered high risk. You may be asked to get an MRI and help the team see if it works well as a screening test.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your PSA blood test is between 1.0 and 2.5 (ng/dL)
- You’re considered high risk (for example, Black race, a close family member with prostate cancer, or certain inherited gene risks)
- You’re willing to take part in prostate cancer screening
- You can legally and mentally agree to take part (informed consent)
- Your prostate exam is not described as firm or lumpy
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses a special kind of MRI to better “map” prostate cancer inside the prostate. Researchers compare the MRI results with the detailed tissue exam after prostate surgery to see how accurate the imaging is.
This study uses a special type of MRI to look at suspicious spots in the prostate. It may help doctors decide if you need a biopsy or can safely avoid one.
This study tests a new MRI platform to better identify prostate issues before a biopsy. It is for people with elevated PSA whose doctor is considering a biopsy.
This study is testing an approach to find prostate cancer earlier in men who may be at higher risk. If you fit the criteria, you may get an mpMRI scan before undergoing a prostate biopsy to check for cancer.
This study compares how well a doctor’s MRI reading (the PI-RADS score) and a computer AI tool detect prostate cancer. It may help improve how men get targeted biopsies and avoid missing important cancers.
This trial studies special MRI images to learn how well they can find prostate cancer before treatment. It may help doctors choose better next steps during biopsy or during active surveillance.
Hear when a new Prostate cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.